Nuwellis Inc (NASDAQ: NUWE) has experienced a decline in its stock price by -5.00 compared to its previous closing price of 0.18. However, the company has seen a gain of 18.75% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-30 that MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the first quarter of 2024 on Tuesday, May 7, 2024. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update.
Is It Worth Investing in Nuwellis Inc (NASDAQ: NUWE) Right Now?
The stock has a 36-month beta value of 0.32. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NUWE is 6.80M, and at present, short sellers hold a 12.45% of that float. On May 07, 2024, the average trading volume of NUWE was 2.73M shares.
NUWE’s Market Performance
NUWE’s stock has seen a 18.75% increase for the week, with a -53.92% drop in the past month and a -64.37% fall in the past quarter. The volatility ratio for the week is 38.66%, and the volatility levels for the past 30 days are at 24.06% for Nuwellis Inc. The simple moving average for the past 20 days is -38.48% for NUWE’s stock, with a -81.38% simple moving average for the past 200 days.
NUWE Trading at -56.63% from the 50-Day Moving Average
After a stumble in the market that brought NUWE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.27% of loss for the given period.
Volatility was left at 24.06%, however, over the last 30 days, the volatility rate increased by 38.66%, as shares sank -55.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -72.01% lower at present.
During the last 5 trading sessions, NUWE rose by +18.75%, which changed the moving average for the period of 200-days by -92.66% in comparison to the 20-day moving average, which settled at $0.2673. In addition, Nuwellis Inc saw -70.56% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NUWE
Current profitability levels for the company are sitting at:
- -1.99 for the present operating margin
- 0.56 for the gross margin
The net margin for Nuwellis Inc stands at -2.28. The total capital return value is set at -2.67. Equity return is now at value -263.36, with -117.35 for asset returns.
Based on Nuwellis Inc (NUWE), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -41.05. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is -4.28.
Currently, EBITDA for the company is -17.27 million with net debt to EBITDA at 0.17. When we switch over and look at the enterprise to sales, we see a ratio of -0.19. The receivables turnover for the company is 4.54for trailing twelve months and the total asset turnover is 0.91. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.59.
Conclusion
To sum up, Nuwellis Inc (NUWE) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
